HuGE Literature Finder
Records 1 - 6
| SNPs in the interleukin-12 signaling pathway are associated with breast cancer risk in Puerto Rican women.
Oncotarget 2020 9 11 (37): 3420-3431.
Núñez-Marrero Angel, Arroyo Nelly, Godoy Lenin, Rahman Mohammad Zillur, Matta Jaime L, Dutil Jul
| Individual Genetic Variation Might Predict Acute Skin Reactions in Women Undergoing Adjuvant Breast Cancer Radiotherapy.
Anticancer research 2018 Dec 38 (12): 6763-6770.
Oliva Delmy, Nilsson Mats, Strandéus Michael, Andersson Bengt-Åke, Sharp Lena, Laytragoon-Lewin Nongnit, Lewin Fred
| BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer.
Oncotarget 2018 5 9 (25): 17501-17511.
Wieser Verena, Gaugg Inge, Fleischer Martina, Shivalingaiah Giridhar, Wenzel Soeren, Sprung Susanne, Lax Sigurd F, Zeimet Alain G, Fiegl Heidelinde, Marth Christi
| Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.
American journal of translational research 2018 10 (6): 1677-1689.
Jin Zining, Xu Lu, Zhang Lei, Zhao Min, Li Dongbao, Ye Lijun, Ma Ying, Ren Siyu, Yu Hailan, Wang Danyu, Liang Chunyan, Chen
| Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
Breast cancer research and treatment 2011 Apr 126 (2): 333-43.
Pal Ranjana, Gochhait Sailesh, Chattopadhyay Shilpi, Gupta Pawan, Prakash Neeraj, Agarwal Gaurav, Chaturvedi Arun, Husain Nuzhat, Husain Syed Akhtar, Bamezai Rameshwar N
| Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer.
Immunogenetics 2005 May 57 (3-4): 165-71.
Saha Anjana, Dhir Ashish, Ranjan Anand, Gupta Vibhuti, Bairwa Narendra, Bamezai Rame
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: